Skip to content
10-Q

Quarterly Report

TEVA PHARMACEUTICAL INDUSTRIES LIMITED TEVA TEVJF

0001193125-25-266895

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 1.16B sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.16B sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.13B sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.13B sh
Shares Outstanding Q3 2025 · Sep 30, 2025 1.15B sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 $369M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $491M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $693M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $672M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $2.2B
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.3B
Stockholders Equity Q3 2025 · Sep 30, 2025 $7.25B
Stockholders Equity Q3 2025 · Dec 31, 2024 $5.37B
Current Liabilities Q3 2025 · Sep 30, 2025 $11.49B
Current Liabilities Q3 2025 · Dec 31, 2024 $12.8B
Total Liabilities Q3 2025 · Sep 30, 2025 $32.6B
Total Liabilities Q3 2025 · Dec 31, 2024 $33.61B
Current Assets Q3 2025 · Sep 30, 2025 $12.74B
Current Assets Q3 2025 · Dec 31, 2024 $12.55B
Total Assets Q3 2025 · Sep 30, 2025 $39.86B
Total Assets Q3 2025 · Dec 31, 2024 $39.33B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.37
Eps Diluted Q3 2025 · Sep 30, 2025 $0.80
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.39
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.26
Eps Basic Q3 2025 · Sep 30, 2025 $0.38
Eps Basic Q3 2025 · Sep 30, 2025 $0.81
Eps Basic Q3 2025 · Sep 30, 2024 −$0.39
Eps Basic Q3 2025 · Sep 30, 2024 −$1.26
Sga Expense Q3 2025 · Sep 30, 2025 $317M
Sga Expense Q3 2025 · Sep 30, 2025 $920M
Sga Expense Q3 2025 · Sep 30, 2024 $298M
Sga Expense Q3 2025 · Sep 30, 2024 $859M
Net Income Q3 2025 · Sep 30, 2025 $433M
Net Income Q3 2025 · Sep 30, 2025 $930M
Net Income Q3 2025 · Sep 30, 2024 −$437M
Net Income Q3 2025 · Sep 30, 2024 −$1.42B
Operating Income Q3 2025 · Sep 30, 2025 $882M
Operating Income Q3 2025 · Sep 30, 2025 $1.86B
Operating Income Q3 2025 · Sep 30, 2024 −$51M
Operating Income Q3 2025 · Sep 30, 2024 −$274M
Gross Profit Q3 2025 · Sep 30, 2025 $2.3B
Gross Profit Q3 2025 · Sep 30, 2025 $6.28B
Gross Profit Q3 2025 · Sep 30, 2024 $2.15B
Gross Profit Q3 2025 · Sep 30, 2024 $5.94B
Cost Of Revenue Q3 2025 · Sep 30, 2025 $2.18B
Cost Of Revenue Q3 2025 · Sep 30, 2025 $6.26B
Cost Of Revenue Q3 2025 · Sep 30, 2024 $2.18B
Cost Of Revenue Q3 2025 · Sep 30, 2024 $6.37B
Revenue Q3 2025 · Sep 30, 2025 $4.48B
Revenue Q3 2025 · Sep 30, 2025 $12.55B
Revenue Q3 2025 · Sep 30, 2024 $4.33B
Revenue Q3 2025 · Sep 30, 2024 $12.32B